JMVSX
Price
$35.26
Change
-$0.05 (-0.14%)
Updated
Jul 31 closing price
Net Assets
11.16B
VEVYX
Price
$51.05
Change
-$0.01 (-0.02%)
Updated
Jul 31 closing price
Net Assets
15.07B
Interact to see
Advertisement

JMVSX vs VEVYX

JMVSX vs VEVYX Comparison Chart in %
View a ticker or compare two or three
VS
JMVSX vs. VEVYX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVSX is a Buy and VEVYX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEVYX has more cash in the bank: 15.1B vs. JMVSX (11.2B). VEVYX pays higher dividends than JMVSX: VEVYX (1.12) vs JMVSX (0.77). JMVSX was incepted earlier than VEVYX: JMVSX (25 years) vs VEVYX (14 years). JMVSX (0.95) is less costly to investors than VEVYX (0.66). VEVYX is a more actively managed with annual turnover of: 45.00 vs. JMVSX (39.00). JMVSX (1000000) and VEVYX (1000000) have matching initial minimum investment requirements. VEVYX annual gain was more profitable for investors over the last year : 12.17 vs. JMVSX (-2.75). VEVYX return over 5 years is better than : 8.04 vs. JMVSX (-17.66).
JMVSXVEVYXJMVSX / VEVYX
Total Expense Ratio0.840.66127%
Annual Report Gross Expense Ratio0.950.66144%
Fund Existence25 years14 years-
Gain YTD13.44914.36794%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets11.2B15.1B74%
Annual Yield % from dividends0.771.1269%
Returns for 1 year-2.7512.17-23%
Returns for 3 years1.2210.3812%
Returns for 5 years-17.668.04-219%
Returns for 10 years5.9470.658%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJGRX45.870.53
+1.17%
PGIM Jennison Growth R
GPEIX11.670.13
+1.13%
Grandeur Peak Emerg Mkts Opps Instl
NMUEX12.520.11
+0.89%
Neuberger Multi-Cap Opportunities E
SLADX45.450.38
+0.84%
Selected American Shares D
HGHTX50.23-0.41
-0.81%
Hartford Healthcare R5